Nodexus

company

About

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Nodexus is a Venture- and SBIR-backed biotech startup commercializing the NX One platform to address widespread unmet needs for accessible live single cell isolation in industrial/biopharma, clinical research, and academic sectors. The NX One platform consists of a low-infrastructure, low-cost hardware system and single-use disposable microfluidic cartridges tailored toward live single-cell workflows involving gene editing (e.g. CRISPR engineering), cell line/antibody development, and tumor heterogeneity studies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Nodexus has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jul 11, 2019 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 11, 2019 Grant 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Nodexus is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant